Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,230,000 | 5,488,000 | 4,797,000 | 6,916,000 | 7,841,000 |
| Marketable Securities | 165,000 | 220,000 | 149,000 | 188,000 | 191,000 |
| Receivables | 14,815,000 | 14,831,000 | 13,547,000 | 12,622,000 | 12,225,000 |
| Inventories | 5,884,000 | 5,288,000 | 5,662,000 | 5,667,000 | 5,337,000 |
| Other current assets | 45,000 | 0 | 0 | 0 | 0 |
| TOTAL | $26,139,000 | $25,827,000 | $24,155,000 | $25,393,000 | $25,594,000 |
| Non-Current Assets | |||||
| PPE Net | 10,819,000 | 10,252,000 | 10,135,000 | 9,630,000 | 9,411,000 |
| Investments And Advances | 1,900,000 | 2,082,000 | 2,464,000 | 2,088,000 | 1,908,000 |
| Intangibles | 58,680,000 | 58,202,000 | 60,533,000 | 60,486,000 | 58,812,000 |
| Other Non-Current Assets | 8,715,000 | 7,672,000 | 7,635,000 | 6,743,000 | 6,568,000 |
| TOTAL | $80,114,000 | $78,208,000 | $80,767,000 | $78,947,000 | $76,699,000 |
| Total Assets | $106,253,000 | $104,035,000 | $104,922,000 | $104,340,000 | $102,293,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,403,000 | 2,337,000 | 1,253,000 | 5,067,000 | 6,050,000 |
| Accounts payable and accrued liabilities | 22,544,000 | 22,465,000 | 21,684,000 | 20,463,000 | 19,699,000 |
| Other current liabilities | 1,171,000 | 1,319,000 | 1,204,000 | 1,219,000 | 1,240,000 |
| TOTAL | $29,129,000 | $27,866,000 | $25,926,000 | $28,566,000 | $28,901,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,692,000 | 26,506,000 | 28,887,000 | 27,225,000 | 27,259,000 |
| Other Non-Current Liabilities | 5,743,000 | 5,486,000 | 5,732,000 | 5,617,000 | 6,011,000 |
| TOTAL | $35,993,000 | $35,298,000 | $38,191,000 | $36,176,000 | $35,891,000 |
| Total Liabilities | $65,122,000 | $63,164,000 | $64,117,000 | $64,742,000 | $64,792,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 388,000 | 388,000 |
| Retained earnings | 3,364,000 | 3,160,000 | 3,138,000 | 1,847,000 | -212,000 |
| Other shareholders' equity | 2,146,000 | 2,097,000 | 2,076,000 | 2,164,000 | 2,131,000 |
| TOTAL | $41,131,000 | $40,871,000 | $40,805,000 | $39,598,000 | $37,501,000 |
| Total Liabilities And Equity | $106,253,000 | $104,035,000 | $104,922,000 | $104,340,000 | $102,293,000 |